Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients.

Li K, Qiu X, Zhang J, Zhou Y, Fan Y, Sun Q

Open source

DOI
10.3389/fmed.2025.1665823
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1665823,
  title = {Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients.},
  author = {Li K and Qiu X and Zhang J and Zhou Y and Fan Y and Sun Q},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1665823},
  url = {https://doi.org/10.3389/fmed.2025.1665823}
}

RIS

TY  - JOUR
TI  - Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients.
AU  - Li K
AU  - Qiu X
AU  - Zhang J
AU  - Zhou Y
AU  - Fan Y
AU  - Sun Q
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1665823
UR  - https://doi.org/10.3389/fmed.2025.1665823
ER  - 

APA

K, L., X, Q., J, Z., Y, Z., Y, F., & Q, S. (2025). Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1665823

Source records